FAM20C and breast carcinoma: Complex roles of FAM20C activity in the TME are indicated by a mouse model of breast cancer metastasis to bone, in which deletion of fam20C from myeloid cells promoted osteoclast differentiation and bone resorption through increased osteopontin secretion.